Long-term outcomes of surgical therapies for Parkinson's disease

Movement Disorders

Volumn 27, Issue 14, 2012, Pages 1718-1728

  Rodriguez Oroz, Maria C ^a,b,c   Moro, Elena ^d   Krack, Paul ^e,f  

^a HOSPITAL DONOSTIA   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

Author keywords

Deep brain stimulation; Long term evolution; Parkinson's disease; Surgery

Indexed keywords

LEVODOPA;

AKINESIA; ANXIETY; APATHY; APRAXIA; BODY POSTURE; BRADYKINESIA; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; DEPRESSION; DISEASE COURSE; DYSARTHRIA; DYSPHONIA; FOLLOW UP; GAIT DISORDER; GLOBUS PALLIDUS; HUMAN; LONG TERM CARE; MOTOR PERFORMANCE; MULTICENTER STUDY (TOPIC); MUSCLE RIGIDITY; OUTCOME ASSESSMENT; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SPEECH DISORDER; SUBTHALAMUS; SUICIDAL IDEATION; SUICIDE ATTEMPT; THALAMOTOMY; THALAMUS; TREATMENT RESPONSE; TREMOR; VISUAL HALLUCINATION;

DEEP BRAIN STIMULATION; FOLLOW-UP STUDIES; HUMANS; MOTOR ACTIVITY; PARKINSON DISEASE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871815778     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25214     Document Type: Review

References (72)

1. Speelman JD, Bosch DA. Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective. Mov Disord 1998; 13: 582-588.
2. Hariz MI. From functional neurosurgery to "interventional" neurology: survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001. Mov Disord 2003; 18: 845-852.
3. Hoehn MM, Yahr M, Gillingham FJ, Donaldson IML. Evaluation of the long term results of surgical therapy. Third symposium on Parkinsonïs disease. Edinburgh: Livingstone; 1969: 274-280.
4. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992; 76: 53-61.
5. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13: 281-285.
6. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337: 403-406.
7. Fox SH, Katzenschlager R, Lim SY, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011; 26( Suppl 3): S2-S41.
8. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21( Suppl 14): S290-S304.
9. Krack P, Batir A, Van Blercom N, P, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
10. Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011; 68: 1550-1556.
11. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1640-1644.
12. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord 2009; 24: 557-563.
13. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 2008; 14: 114-119.
14. Gervais-Bernard H, Xie-Brustolin J, Mertens P, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 2009; 256: 225-233.
15. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010; 25: 578-586.
16. Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010; 133: 2664-2676.
17. Zibetti M, Merola A, Rizzi L, et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord 2011; 26: 2327-2334.
18. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for Parkinson's disease. Neurology 2002; 59: 932-934.
19. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002; 125: 575-583.
20. Piboolnurak P, Lang AE, Lozano AM, et al. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord 2007; 22: 990-997.
21. Merola A, Zibetti M, Artusi CA, et al. Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? J Neurol Neurosurg Psychiatry 2012; 83: 251-257.
22. Merola A, Zibetti M, Angrisano S, et al. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 2011; 134: 2074-2084.
23. Voon V, Kubu C, Krack P, Houeto JL, Troster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21( Suppl 14): S305-S327.
24. Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors, and underlying mesolimbic denervation. Brain 2010; 133: 1111-1127.
25. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131: 2720-2728.
26. Umemura A, Oka Y, Yamamoto K, Okita K, Matsukawa N, Yamada K. Complications of subthalamic nucleus stimulation in Parkinson's disease. Neurol Med Chir (Tokyo) 2011; 51: 749-755.
27. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595.
28. Lim SY, O'Sullivan SS, Kotschet K, et al. Dopamine dysregulation syndrome, impulse control disorders, and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009; 16: 1148-1152.
29. Mandat TS, Hurwitz T, Honey CR. Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases. Acta Neurochir (Wien) 2006; 148: 895-897; discussion, 8.
30. Raucher-Chene D, Charrel CL, de Maindreville AD, Limosin F. Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation: improvement on switching the target. J Neurol Sci 2008; 273: 116-117.
31. Mallet L, Mesnage V, Houeto JL, et al. Compulsions, Parkinson's disease and stimulation. Lancet 2002; 360: 1302-1304.
32. Fraix V, Houeto JL, Lagrange C, et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 443-449.
33. Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004; 55: 871-875.
34. Rehncrona S, Johnels B, Widner H, Törnqvist AL, Hariz M, Sydow O. Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord. 2003; 18: 163-170.
35. Tarsy D, Scollins L, Corapi K, O'Herron S, Apetauerova D, Norregaard T. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor. Stereotact Funct Neurosurg 2005; 83: 222-227.
36. Kumar R, Lozano A, Sime E, Lang A. Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor. Neurology 2003; 61: 1601-1604.
37. Pahwa R, Lyons KE, Wilkinson SB, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg 2006; 104: 506-512.
38. Hariz MI, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry 2008; 79: 694-699.
39. Merello M, Starkstein S, Nouzeilles MI, Kuzis G, Leiguarda R. Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globu spallidus lesion combined with contralateral stimulation. J Neurol Neurosurg Psychiatry 2001; 71: 611-614.
40. Hariz MI, Bergenheim AT. A 10-year follow-up review of patients who underwent Leksell's posteroventral pallidotomy for Parkinson' s disease. J Neurosurg 2001; 94: 552-558.
41. Fine J, Duff J, Chen R, et al. Long-term follow-up of unilateral pallidotomy in advanced Parkinsonïs disease. N Engl J Med 2000; 342: 1708-1714.
42. Strutt AM, Lai EC, Jankovic J, et al. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol 2009; 71: 551-558.
43. Kleiner-Fisman G, Lozano A, Moro E, Poon YY, Lang AE. Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia. Mov Disord 2010; 25: 1496-1498.
44. Kelly PJ, Gillingham FJ. The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study. J Neurosurg 1980; 53: 332-337.
45. Speelman JD. Parkinson's Disease and Stereotaxic Neurosurgery. Amsterdam: Rodopi; 1991.
46. Schuurman PR, Bosch DA, Merkus MP, Speelman JD. Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression. Mov Disord 2008; 23: 1146-1153.
47. Miyamoto T, Bekku H, Moriyama E, Tsuchida S. Present role of stereotactic thalamotomy for parkinsonism. Retrospective analysis of operative results and thalamic lesions in computed tomograms. Appl Neurophysiol 1985; 48: 294-304.
48. Moriyama E, Beck H, Miyamoto T. Long-term results of ventrolateral thalamotomy for patients with Parkinson's disease. Neurol Med Chir (Tokyo) 1999; 39: 350-356; discussion, 6-7.
49. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998; 121: 451-457.
50. Deep-Brain Stimulation for Parkinsonïs Disease Study G. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinsonïs disease. N Engl J Med 2001; 345: 956-963.
51. Houeto JL, Bejjani PB, Damier P, et al. Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology 2000; 55: 728-730.
52. Mallet L, Schupbach M, N'Diaye K, et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A 2007; 104: 10661-10666.
53. Krack P, Hariz MI, Baunez C, Guridi J, Obeso JA. Deep brain stimulation: from neurology to psychiatry? Trends Neurosci 2010; 33: 474-484.
54. Lhommée E Klinger H, Thobois S, et al. Subhtalamic stimulation in Parkinson's disease: restoring the balance of motivated behviours. Brain 2012; 135: 1463-1477.
55. Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002; 17( Suppl 3): 188-197.
56. Witjas T, Baunez C, Henry JM, et al. Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation. Mov Disord 2005; 20: 1052-1055.
57. Ardouin C, Voon V, Worbe Y, et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006; 21: 1941-1946.
58. Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010; 6: 487-498.
59. Troster AI. Neuropsychology of deep brain stimulation in neurology and psychiatry. Front Biosci 2009; 14: 1857-1879.
60. Witt K, Daniels C, Krack P, et al. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease. J Neurol Sci 2011; 310: 261-266.
61. Anderson VC, Burchiel K, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson's disease. Arch Neurol 2005; 62: 554-560.
62. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077-2091.
63. Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012; 79: 55-65.
64. Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011; 68: 165.
65. Krack P, Hariz MI. Parkinson disease: deep brain stimulation in Parkinson disease-what went wrong? Nat Rev Neurol 2010; 6: 535-536.
66. Klostermann F, Jugel C, Marzinzik F. Jejunal levodopa infusion in long-term DBS patients with Parkinson's disease. Mov Disord 2011; 26: 2298-2299.
67. Moreau C, Defebvre L, Destee A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 2008; 71: 80-84.
68. Ferraye MU, Debu B, Fraix V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010; 133: 205-214.
69. Moro E, Hamani C, Poon YY, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010; 133: 215-224.
70. Bejjani BPW, Jabre MG, Nohra G. The new phenotype of Parkinson's disease: the post-subthalamic stimulation era. Neurology 2008;( Suppl 1): A179
71. Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005; 20: 190-199.
72. Obeso JA, Olanow W. Deep brain stimulation for Parkinson's disease: thinking about the long-term in the short-term. Mov Disord 2011; 26: 2303-2304.